HIGHLIGHTS
- who: . and collaborators from the Miguel Hernu00e1ndez University of Elche, Spain have published the Article: Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic, in the Journal: (JOURNAL)
- what: To verify in a controlled study if the anxiolytic effect of CBD persists for at least 4 weeks after its discontinuation, in the present paper, the authors conducted a 3-month follow-up of the clinical trial with frontline HCWs (Crippa et_al, 2021) and compare this group with similar demographic and professional characteristics control group from another study conducted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.